Investor FAQ

Juno Therapeutics, Inc. was incorporated in Delaware in August 2013.

Juno is headquartered in Seattle, WA.

Juno’s fiscal year ends December 31st.

Ernst & Young LLP is Juno’s independent registered public accounting firm.

Juno’s common stock is traded under the ticker symbol “JUNO” on The NASDAQ Global Select Stock Market. Juno’s initial public offering was in December 2014.

Shares can be purchased through a stockbroker of your choice. Juno does not have a direct stock purchase program.

Juno has never declared or paid any cash dividends on our common stock or any other securities. Juno anticipates that it will retain all available funds and any future earnings, if any, for use in the operation of Juno’s business and does not anticipate paying cash dividends in the foreseeable future.

48205A 109

If you are a direct stockholder and have questions about your Juno Therapeutics account, please contact our transfer agent, Wells Fargo Shareowner Services:
Contact our transfer agent by phone:
Toll Free at 1-800-468-9716
Outside the US at 651-450-4064
Hours of Operation: Monday – Friday 7AM to 7PM CST

Send written correspondence to our transfer agent:
Wells Fargo Shareowner Services
PO Box 64874
St Paul MN 55164-0874

Overnight Mail:
Wells Fargo Shareowner Services
1110 Centre Pointe Curve, Suite 101
Mendota Heights MN 55120-4100

Access your account online:
www.shareowneronline.com

If you are a direct stockholder and have activated your account at www.shareowneronline.com, you may change your address online. Otherwise, if you are a direct stockholder, please contact Wells Fargo Shareowner services by phone or mail. If you hold your shares in “street” name through a broker or other investment institution, you should contact your broker or investment institution.
Contact our transfer agent by phone:
Toll Free at 1-800-468-9716
Outside the US at 651-450-4064
Hours of Operation: Monday – Friday 7AM to 7PM CST

Send written correspondence to our transfer agent:
Wells Fargo Shareowner Services
PO Box 64874
St Paul MN 55164-0874

Overnight Mail:
Wells Fargo Shareowner Services
1110 Centre Pointe Curve, Suite 101
Mendota Heights MN 55120-4100
 

Electronic copies of our Annual Report and other periodic reports are available on this website. If you would like to request paper copies of the Annual Report or other periodic reports, send your request in writing to:
Juno Therapeutics, Inc.
Attn: Corporate Secretary
400 Dexter Avenue N, Suite 1200
Seattle, WA 98109

Please use the Investor Contacts page on the Juno website for additional questions or inquiries.